Table 1. Genotype and number of viable progeny from crosses between afadinflox/+;Tie2-Cre and afadinflox/flox mice.
Afadinflox/flox;Tie2-Cre | Afadinflox/+;Tie2-Cre | Afadinflox/flox | Afadinflox/+ | ||||||
E9.5 | 15 | (34.1) | 15 | (34.1) | 11 | (25.0) | 3 | (6.8) | |
E10.5 | 11 | (25.0) | 12 | (27.3) | 9 | (20.5) | 12 | (27.3) | |
E11.5 | 3 | (33.3) | 3 | (33.3) | 2 | (22.2) | 1 | (11.1) | |
E12.5 | 5 | (20.8) | 9 | (37.5) | 6 | (25.0) | 4 | (16.7) | |
E13.5 | 2 | (15.4) | 6 | (46.2) | 2 | (15.4) | 3 | (23.1) | |
E14.5 | 7 | (10.8) | [6] | 20 | (30.8) | 19 | (29.2) | 19 | (29.2) |
E15.5 | 10 | (18.5) | [10] | 18 | (33.3) | 16 | (29.6) | 10 | (18.5) |
E16.5 | 1 | (3.6) | 9 | (32.1) | 13 | (46.4) | 5 | (17.9) | |
P0 | 9 | (4.8) | 69 | (37.1) | 53 | (28.5) | 55 | (29.6) | |
P21 | 6 | (3.6) | 62 | (36.7) | 47 | (27.8) | 54 | (32.0) |
The percentage of each genotype relative to the total progeny at each embryonic and post natal day is shown in parentheses (). The number of mice with an abnormal phenotype is shown in brackets [ ].